Pharma Mar SA

PHM
Real-time TRADEGATE AG - 07/23 02:21:46 pm
1.851EUR
+2.37%
Prev.1.8570
Open1.8800
High1.8800
Low1.8280
Volume852 619
Financials
Sales 2019 138 M
EBIT 2019 -27,2 M
Net income 2019 -31,0 M
Debt 2019 74,3 M
Yield 2019 -
P/E ratio 2019 -13,3x
P/E ratio 2020 15,5x
EV / Sales2019 3,52x
EV / Sales2020 3,53x
Capitalization 411 M
Company
Pharma Mar SA is a Spain-based company engaged in the bio therapeutic drugs manufacture. The Company focuses on research, development and marketing of bio-active principles, primarily from marine origin, for application in human diseases treatment, including antitumour, antiviral and...
Sector :
Biopharmaceuticals
Calendar :
2019-10-28 Earnings Release
Trading Rating : -
Investor Rating :
Latest news
04/29PHARMA MAR : PharmaMar and Luye Pharma sign License agreement for Development and Commercialization of lurbinectedin in China territories
AQ
04/26PHARMA MAR : Calificaciones crediticias
PU
04/09PHARMA MAR : PharmaMar announces its new immunotherapy research program
PU
04/08PHARMA MAR : PharmaMar is present with its ATLANTIS study at the IASLC Congress on small cell lung cancer in New York
PU
04/01PHARMA MAR : ASCO selects PharmaMar's lurbinectedin monotherapy trial for an oral presentation
PU
04/01R&D : new licenses, patents and registered trademarks
PU
03/26PHARMA MAR : PharmaMar to attend the China Healthcare Investment Conference (CHIC)
PU
03/25R&D : new licenses, patents and registered trademarks
PU
Technical analysis trends
Short TermMid-TermLong Term
TrendBearishBullishBullish
Resistance1,942,402,40
Spread/Res.-5,0%-23%-23%
Spread/Supp.5,4%8,0%23%
Support1,751,711,50